Alimentary Pharmacology & Therapeutics· 2026Q1
Association Between Proton Pump Inhibitor Use and Gastric Neuroendocrine Neoplasms in Autoimmune Gastritis: A Real‐World Propensity Score‐Matched Study From the Autoimmune gastRitis Italian netwOrk Study grOup
- 2citations
- Q1SCImago
- 2026year
Short summary
Proton pump inhibitor (PPI) use is associated with a 49% higher risk of gastric neuroendocrine neoplasms (gNENs) in patients with autoimmune gastritis (AIG), according to a real-world study of over 40,000 matched patients.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Surgery
SurgeryMedicine